The Role of Melatonin in Acute Cerebral Circulatory Accidents: A Comprehensive Review and Analysis
Botirov Xushnud Xasanbayevich , Neurologist, Tashkent Emergency Medical Care Clinical Hospital, Tashkent, UzbekistanAbstract
Acute cerebral circulatory accidents (stroke) represent a leading cause of mortality and long-term disability worldwide. Despite advances in acute management, neuroprotection and post-stroke rehabilitation remain challenging. Melatonin (MT), a neurohormone regulating circadian rhythms, has emerged as a promising neuroprotective agent due to its potent antioxidant, anti-inflammatory, and mitochondrial-protective properties. This review synthesizes current literature on the relationship between sleep disturbances, circadian disruption, and stroke outcomes, with a specific focus on melatonin’s therapeutic potential. We analyze data from clinical studies, quantitative electroencephalography (QEEG) findings, and epidemiological reports. Results indicate that melatonin levels decline with age, coinciding with increased stroke risk, and that exogenous melatonin administration during the acute phase of ischemic stroke may improve neurological recovery, reduce oxidative stress, and normalize sleep architecture. We present averaged-index tables and figures illustrating melatonin’s effects on EEG spectral power, infarct volume, and functional outcomes. This review concludes that melatonin is a safe, accessible adjunct therapy for acute ischemic stroke, though larger randomized controlled trials are needed.
Keywords
Melatonin, acute cerebral circulatory accident, ischemic stroke
References
Bassetti, C., & Aldrich, M.S. (1999). Sleep apnea in acute cerebrovascular diseases. Final report on 128 patients. Sleep, 22, 217-223.
Chen, X., et al. (2015). Research of sleep disorders in patients with acute cerebral infarction. Journal of Stroke and Cerebrovascular Diseases, 24(11), 2508-2513.
Dyumaev, K.M., Voronina, T.A., & Smirnov, L.D. (1995). Antioxidants in the prevention and treatment of central nervous system pathologies. Moscow: Publishing House of the Institute of Biomedical Chemistry, Russian Academy of Medical Sciences.
Feigin, V.L., et al. (2014). Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet, 383(9913), 245-254.
Feigin, V.L., et al. (2016). Prevention of stroke: a strategic global imperative. Nature Reviews Neurology, 12(9), 501-512.
Gasanov, R.L. (2000). Brain functioning in the “wakefulness-sleep” cycle in patients after stroke (Doctoral dissertation). Moscow.
Grivas, T.B., Vasilidis, E.S., Triantafyllopoulos, G., Kaspiris, A., & Burwell, R.G. (2009). Age variations of melatonin level and its hormesis; implications for AIS and osteoporosis. Scoliosis, 4(Suppl 2), O8.
Howard, G., & Goff, D.C. (2012). Population shifts and the future of stroke: forecasts of the future burden of stroke. Annals of the New York Academy of Sciences, 1268, 14-20.
Kim, B. (2017). Risk factors and functional impact of medical complications in stroke. Annals of Rehabilitation Medicine, 41(5), 753-760.
Kovaleva, N.S. (2011). Use of quantitative electroencephalography in ischemic stroke under conditions of melatonin use (Candidate’s dissertation).
Leppavuori, A., et al. (2002). Insomnia in ischemic stroke patients. Cerebrovascular Diseases, 14, 90-97.
Levin, Ya.I., & Poluyektov, M.G. (2013). Somnology and sleep medicine. Selected lectures. Moscow: Medforum.
Meerlo, P., Benca, R.M., & Abel, T. (Eds.). (2015). Sleep, neuronal plasticity and brain function. Springer.
Müller, C., et al. (2002). Visual and spectral analysis of sleep EEG in acute hemispheric stroke. European Neurology, 48, 164-171.
Omelchenko, V.P., & Matua, S.P. (2007). Experience of using the multivariate method for quantitative EEG analysis. In Proceedings of the All-Russian scientific and practical conference “Quantitative EEG and neurotherapy” (pp. 71-72). St. Petersburg.
Poluyektov, M.G., & Tsenteradze, S.L. (2015). The influence of sleep disorders on the occurrence and course of cerebral stroke. Medical Council, 2, 10-15.
Skvortsova, V.I. (2005). Treatment of acute ischemic stroke. In Man and Medicine. Lectures for practicing physicians: Proceedings of the 11th Russian National Congress (pp. 196-222). Moscow.
Terzoudi, A., et al. (2009). Sleep architecture in stroke and relation to outcome. European Neurology, 61, 16-22.
Uddin, M.S., Hoque, M.I., Uddin, M.K., Kamol, S.A., & Chowdhury, R.H. (2015). Circadian rhythm of onset of stroke – in 50 cases of ischemic stroke. Mymensingh Medical Journal, 24, 121-126.
Wu, M.-P., Lin, H.-J., Weng, S.-F., Ho, C.-H., et al. (2014). Insomnia subtypes and the subsequent risks of stroke report from a nationally representative cohort. Stroke, 45, 1349-1354.
Zhang, Y., Liu, L., Zhao, S., Yan, S., Zeng, F., & Zhou, D. (2022). A new perspective on ischemic stroke: circadian rhythm in post-stroke angiogenesis. Frontiers in Pharmacology, 13, 927506.
Download and View Statistics
Copyright License
Copyright (c) 2026 Botirov Xushnud Xasanbayevich

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.


Medical Science
| Open Access |
DOI: